Profectus BioSciences Inc., a Baltimore-based biotechnology company, has completed an additional $3million private equity placement.
The private equity placement is the result of the sale of securities to private investors led by Cross Atlantic Capital Partners.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.